Patent Assignment
Reel/Frame 056572/0902
Assignment of Assignor's Interest
Recorded: 2021-06-17
Pages: 6
Assignors
ALLERSON, CHARLES R.
Executed: 2019-01-16
NEBEN, STEVEN S.
Executed: 2019-01-08
WRIGHT, TIMOTHY
Executed: 2019-01-15
Assignee
REGULUS THERAPEUTICS INC.
10614 SCIENCE CENTER DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(2)
Microrna Compounds and Methods for Modulating Mir-122
PCT:
PCT/US2019/031044 ↗
Galnac Conjugated Modified Oligonucleotides as MIR-122 Inhibitor Having HCV Antiviral Activity with Reduced Hyperbilirubinemia Side-Effect